Once-daily inhaled glucocorticosteroid administration in controlled asthma patients

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2008, Pages 663-667

  Hasegawa, Hirotsugu ^a   Inui, Naoki ^a   Fujisawa, Tomoyuki ^a   Sato, Jun ^a   Nakamura, Hirotoshi ^a   Watanabe, Hiroshi ^a   Suda, Takafumi ^a   Chida, Kingo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adherence; Asthma; Beclomethasone dipropionate; Budesonide; Exhaled nitric oxide; Inhaled glucocorticosteroid; Once daily administration

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADULT; AGED; ASTHMA; BECLOMETHASONE; BREATH TESTS; BUDESONIDE; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; QUALITY OF LIFE;

EID: 47149108886     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.03.001     Document Type: Article

References (34)

1. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 (1990) 1033-1039
2. Global Initiative for Asthma 2006. Global strategy for asthma management and prevention. National Institute of Health, National Heart, Lung, and Blood Institute. revised 2006.
3. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute; 1997. Publication No. 97-4051.
4. Juniper E.F., Kline P.A., Vanzieleghem M.A., Ramsdale E.H., O'Byrne P.M., and Hargreave F.E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 142 (1990) 832-836
5. Gaddie J., Petrie G.R., Reid I.W., Skinner C., Sinclair D.J., and Palmer K.N. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet 2 (1973) 280-281
6. Barnes P.J. A new approach to the treatment of asthma. N Engl J Med 321 (1989) 1517-1527
7. Mayo P.H., Richman J., and Harris H.W. Results of a program to reduce admissions for adult asthma. Ann Intern Med 112 (1990) 864-871
8. Chmelik F., and Doughty A. Objective measurements of compliance in asthma treatment. Ann Allergy 73 (1994) 527-532
9. Graves M.M., Adams C.D., and Portnoy J.M. Adherence in young children with asthma. Curr Opin Allergy Clin Immunol 6 (2006) 124-127
10. Eisen S.A., Miller D.K., Woodward R.S., Spitznagel E., and Przybeck T.R. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150 (1990) 1881-1884
11. McFadden E.R., Casale T.B., Edwards T.B., Kemp J.P., Metzger W.J., Nelson H.S., et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J Allergy Clin Immunol 104 (1999) 46-52
12. Gagnon M., Cote J., Milot J., Turcotte H., and Boulet L.P. Comparative safety and efficacy of single or twice-daily administration of inhaled beclomethasone in moderate asthma. Chest 105 (1994) 1732-1737
13. Masoli M., Weatherall M., Holt S., and Beasley R. Budesonide once versus twice-daily administration: meta-analysis. Respirology 9 (2004) 528-534
14. Masoli M., Weatherall M., and Beasley R. Fluticasone given once versus twice a day: meta-analysis. Respirology 10 (2005) 183-188
15. Purucker M.E., Rosebraugh C.J., Zhou F., and Meyer R.J. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. Chest 124 (2003) 1584-1593
16. Weiner P., Weiner M., and Azgad Y. Long term clinical comparison of single versus twice-daily administration of inhaled budesonide in moderate asthma. Thorax 50 (1995) 1270-1273
17. Singer R., and Wood-Baker R. Review of the effect of the dosing interval for inhaled corticosteroids in asthma control. Intern Med J 32 (2002) 72-78
18. Boulet L.P. Once-daily inhaled corticosteroids for the treatment of asthma. Curr Opin Pulm Med 10 (2004) 15-21
19. Juniper E.F., Guyatt G.H., Ferrie P.J., and Griffith L.E. Measuring quality of life in asthma. Am Rev Respir Dis 147 (1993) 832-838
20. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide. Am J Respir Crit Care Med 171 (2005) 912-930
21. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47 (1994) 81-87
22. Kharitonov S.A., Gonio F., Kelly C., Meah S., and Barnes P.J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 21 (2003) 433-438
23. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., and Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53 (1998) 91-95
24. Fahy J.V., Boushey H.A., Lazarus S.C., Mauger E.A., Cherniack R.M., Chinchilli V.M., et al. NHLBI Asthma Clinical Research Network. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 163 (2001) 1470-1475
25. Vignola A.M., Rennar S.I., Hargreave F.E., Fah J.V., Bonsignore M.R., Djukanovic R., et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J 37 (2002) 51-55
26. Kharitonov S.A., and Barnes P.J. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1693-1722
27. Jones S.L., Kittelson J., Cowan J.O., Flannery E.M., Hancox R.J., McLachlan C.R., et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 164 (2001) 738-743
28. Kharitonov S.A., Yates D.H., Chung K.F., and Barnes P.J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 9 (1996) 196-201
29. Mattes J., Storm van's Gravesande K., Reining U., Alving K., Ihorst G., Henschen M., et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J 13 (1999) 1391-1395
30. Kharitonov S.A., Yates D.H., and Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 153 (1996) 454-457
31. Massaro A.F., Gaston B., Kita D., Fanta C., Stamler J.S., and Drazen J.M. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 152 (1995) 800-803
32. Stirling R.G., Kharitonov S.A., Campbell D., Robinson D.S., Durham S.R., Chung K.F., et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids asthma and allergy group. Thorax 53 (1998) 1030-1034
33. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
34. Ricciardolo F.L., Sterk P.J., Gaston B., and Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 84 (2004) 731-765